EZH2 promotes tumor progression via regulating VEGF-A/AKT signaling in non-small cell lung cancer (vol 359, pg 275, 2015)

被引:1
作者
Geng, Jian [1 ,2 ,3 ]
Li, Xiao [4 ]
Zhou, Zhanmei [1 ]
Wu, Chin-Lee [5 ]
Bai, Xiaoyan [1 ]
Dai, Meng [6 ]
机构
[1] Southern Med Univ, Nanfang Hosp, Div Nephrol, Natl Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China
[2] Southern Med Univ, Nanfang Hosp, Dept Pathol, Guangzhou, Guangdong, Peoples R China
[3] Southern Med Univ, Sch Basic Med Sci, Dept Pathol, Guangzhou, Guangdong, Peoples R China
[4] Southern Med Univ, Nanfang Hosp, Dept Emergency, Guangzhou, Guangdong, Peoples R China
[5] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Pathol, Boston, MA 02114 USA
[6] Southern Med Univ, Nanfang Hosp, Hlth Management Ctr, Guangzhou, Guangdong, Peoples R China
关键词
D O I
10.1016/j.canlet.2015.11.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:366 / 366
页数:1
相关论文
共 1 条
[1]   EZH2 promotes tumor progression via regulating VEGF-A/AKT signaling in non-small cell lung cancer [J].
Geng, Jian ;
Li, Xiao ;
Zhou, Zhanmei ;
Wu, Chin-Lee ;
Dai, Meng ;
Bai, Xiaoyan .
CANCER LETTERS, 2015, 359 (02) :275-287